Neuropeptide B-29 (Rat) (Non Brominated Form)

Neuropeptide B-29 (Rat) (Non Brominated Form)

0.5 mg
€300,00

Vous pouvez créer un devis après avoir ajouté le produit au panier.

Passer aux informations sur le produit
Neuropeptide B-29 (Rat) (Non Brominated Form)
  • Neuropeptide B-29 (Rat) (Non Brominated Form)
  • Neuropeptide B-29 (Rat) (Non Brominated Form)

Neuropeptide B-29 (Rat) (Non Brominated Form)

ID du produit: 4459

Trp- Tyr- Lys- Pro- Ala- Ala- Gly- Ser- His- His- Tyr- Ser- Val- Gly- Arg- Ala- Ala- Gly- Leu- Leu- Ser- Ser- Phe- His- Arg- Phe- Pro- Ser- Thr

€300,00
excl. 19% TVA
Description

M.W. 3188.5

C147H211N43O38

Trp- Tyr- Lys- Pro- Ala- Ala- Gly- Ser- His- His- Tyr- Ser- Val- Gly- Arg- Ala- Ala- Gly- Leu- Leu- Ser- Ser- Phe- His- Arg- Phe- Pro- Ser- Thr

Neuropeptide B-29 is a ligand of NPBWR1 (GPR7)

Synthetic Product

The purity is guaranteed to be higher than 99% by HPLC

Références:

1. R. Fujii, H. Yoshida, S. Fukusumi, Y. Habata, M. Hosoya, Y. Kawamata, T. Yano, S. Hinuma, C. Kitada, T. Asami, M. Mori, Y. Fujisawa and M. Fujino, J. Biol. Chem., 277, 34010 (2002) (Original) 2. H. Tanaka, T. Yoshida, N. Miyamoto, T. Motoike, H. Kurosu, K. Shibata, A. Yamanaka, S.C. Williams, J.A. Richardson, N. Tsujino, M.G. Garry, M.R. Lerner, D.S. King, B.F. O’Dowd, T. Sakurai and M. Yanagisawa, Proc. Natl. Acad. Sci. U.S.A, 100, 6251 (2003) (Pharmacol) 3. S. Aikawa, M. Ishii, M. Yanagisawa, Y. Sakakibara and T. Sakurai, Regul. Pept., 151, 147 (2008) (Pharmacol) 4. N. Hirashima, T. Tsunematsu, K. Ichiki, H. Tanaka, T.S. Kilduff and A. Yamanaka, Sleep,in press(Pharmacol)

Téléchargements

Vous pourriez aussi aimer